ArticleJACC. Case reports2026
Chagas Heart Disease: Social Determinants and Delayed Diagnosis.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChagas cardiomyopathy (CCM) is an under-recognized cause of nonischemic cardiomyopathy (NICM) among immigrants from endemic regions or Latin America. CASE SUMMARY: A 60-year-old Guatemalan man with heart failure with reduced ejection fraction presented with dyspnea and was ultimately found positive for Trypanosoma cruzi IgG. He underwent cardiac resynchronization therapy with defibrillator. DISCUSSION: Timely recognition is crucial, as sudden cardiac death accounts for 60% of CCM-related mortality, which is higher than in non-CCM NICM. Early detection, prior to irreversible myocardial damage, also allows for curative antiparasitic therapy, a critical window that is almost always missed in the U.S. TAKE-HOME MESSAGES: Our patient presented with end-stage disease nearly 2 decades after the initial conduction system was documented. This oversight is a systemic failure, where CCM is often mistaken for "idiopathic" NICM given low clinician awareness and lack of routine targeted screening in the U.S., which in this case led to catastrophic and inequitable outcomes in an otherwise treatable infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.